SCHEMBL2732076

SCHEMBL2732076

O=C(O)c1c(I)c2ccccc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 2/20 0.50
FABP4 P15090 2/20 0.50
FABP5 Q01469 2/20 0.50
AGTR1 P30556 4/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTR6 P50406 6/20 0.45
SRC P12931 1/20 0.45
ACLY P53396 1/20 0.45
AKR1C3 P42330 1/20 0.45
AKR1C1 Q04828 1/20 0.45
PLK1 P53350 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
FABP2 P12104 1/20 0.43
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119321 0.82 ACLY (0.51) FABP3FABP4FABP5AGTR1LMNA
SCHEMBL28019783 0.82 AGTR1 (0.47) FABP3FABP4FABP5AGTR1LMNA
SCHEMBL6829775 0.82 AKR1C3 (0.48) FABP3FABP4FABP5AGTR1LMNA
SCHEMBL16655202 0.81 HTR6 (0.47) FABP3FABP4FABP5AGTR1LMNA
SCHEMBL5136341 0.79 HTR6 (0.47) FABP3FABP4FABP5AGTR1LMNA
SCHEMBL2731882 0.77 HTR6 (0.48) HTR6MEN1KMT2APSEN1PSEN2
SCHEMBL12093313 0.76 HTR6 (0.70) FABP3FABP4FABP5LMNAHTR6
SCHEMBL3334758 0.76 AGTR1 (0.51) AGTR1HTR6MEN1KMT2APSEN1
SCHEMBL2733261 0.74 ALDH1A1 (0.43) FABP3FABP4FABP5LMNAMEN1
SCHEMBL20505521 0.73 AGTR1 (0.60) AGTR1SMN1; SMN2HTR6PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012059568-A1 NOVEL WATER-SOLUBLE INDOLOBENZAZEPINE MOLECULES DEMONSTRATING ANTIMITOTIC, ANTIVASCULAR, AND ANTITUMOR ACTIVITIES IN VIVO CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-05-10 WO disclosed